<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PRF</journal-id>
<journal-id journal-id-type="hwp">spprf</journal-id>
<journal-id journal-id-type="nlm-ta">Perfusion</journal-id>
<journal-title>Perfusion</journal-title>
<issn pub-type="ppub">0267-6591</issn>
<issn pub-type="epub">1477-111X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0267659112439597</article-id>
<article-id pub-id-type="publisher-id">10.1177_0267659112439597</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A successful percutaneous closure of ventricular septal defect following septal myectomy in patients with hypertrophic obstructive cardiomyopathy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kilicgedik</surname><given-names>A</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Karabay</surname><given-names>CY</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Aung</surname><given-names>SM</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Guler</surname><given-names>A</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Kalayci</surname><given-names>A</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Tasar</surname><given-names>O</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Kirma</surname><given-names>C</given-names></name>
</contrib>
<aff id="aff1-0267659112439597">Can Yücel Koşuyolu Heart and Research Hospital, Cardiology Clinic, Istanbul, Turkey</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0267659112439597">Dr. Can Yucel Karabay Denizer Street Cevizli/Kartal Istanbul 34628 Turkey Email: <email>karabaymd@yahoo.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>3</issue>
<fpage>253</fpage>
<lpage>255</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Postoperative ventricular septal defect (post-op VSD) after septal myectomy in patients with hypertrophic obstructive cardiomyopathy is a rare and unexpected complication. We report a case of successful percutaneous closure of VSD following septal myectomy and mitral valve replacement in a patient with intrinsic mitral valve disease and severe mitral valve regurgitation together with hypertrophic obstructive cardiomyopathy.</p>
</abstract>
<kwd-group>
<kwd>ventricular septal defect</kwd>
<kwd>septal myectomy</kwd>
<kwd>percutaneous closure</kwd>
<kwd>hypertrophic obstructive cardiomyopathy</kwd>
<kwd>left ventriculogram</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0267659112439597" sec-type="intro">
<title>Introduction</title>
<p>Acquired VSDs usually occur after aortic valve replacement surgery, patch opening after VSD repair, trauma or acute myocardial infarction<sup><xref ref-type="bibr" rid="bibr1-0267659112439597">1</xref></sup>. Post-op VSD after septal myectomy for left ventricular outflow tract (LVOT) obstruction in patients with hypertrophic obstructive cardiomyopathy is a rare complication<sup><xref ref-type="bibr" rid="bibr2-0267659112439597">2</xref></sup>. Because of the high risk of mortality and morbidity, re-operation for repair of the VSD following septal myectomy is an undesirable procedure<sup><xref ref-type="bibr" rid="bibr2-0267659112439597">2</xref>,<xref ref-type="bibr" rid="bibr3-0267659112439597">3</xref></sup>. Percutaneous closure of a VSD can be an attractive alternative to surgery in this condition<sup><xref ref-type="bibr" rid="bibr3-0267659112439597">3</xref>,<xref ref-type="bibr" rid="bibr4-0267659112439597">4</xref></sup>.</p>
</sec>
<sec id="section2-0267659112439597" sec-type="cases">
<title>Case Report</title>
<p>A 68-year-old female was admitted to our hospital with exertional dyspnea. Echocardiography revealed normal left ventricular function, degenerative mitral and aortic valves, severe mitral regurgitation, mild aortic regurgitation, moderate tricuspid regurgitation and systolic anterior motion of the mitral valve. A gradient of 160 mmHg was measured at the LVOT. Cardiac catheterization was performed, and the gradient between the aorta and LVOT was found to be 140 mmHg. Since she was symptomatic under optimal medical therapy and had intrinsic mitral valve disease, she underwent a septal myectomy and mitral valve replacement (No.27 St Jude) operation. Shortly after the operation, she developed high-grade heart block and a VDD pacemaker was implanted. During the follow-up, her symptoms re-occurred. On echocardiogram, mitral mechanical prosthetic valve gradients were normal, there was no leak or mitral regurgitation and a VSD with an estimated diameter of 1.2 cm and a gradient of 70 mmHg was noted. Because of her ongoing symptoms and significant left to right shunt, transcatheter VSD closure was planned. After 6 F sheaths were inserted into the right femoral artery and vein, left ventriculogram was performed and a 12 mm VSD was revealed (<xref ref-type="fig" rid="fig1-0267659112439597">Figure 1A</xref>, supplementary file left panel). A hydrophilic guidewire and multipurpose catheter was passed through the aorta to the left ventricle and then through the right ventricle into the inferior vena cava (IVC). While the multipurpose catheter was kept in the IVC, the hydrophilic wire was exchanged with a more rigid guidewire. A macro snare was advanced from the femoral vein and the guidewire was captured, creating an arteriovenous loop. From the right femoral vein, the catheter of the VSD occlusion device was advanced to the ascending aorta, with special attention paid to the permanent pacemaker lead. A 14 mm Amplatzer VSD occluder device was placed at the defect (<xref ref-type="fig" rid="fig1-0267659112439597">Figure 1B</xref>, <xref ref-type="fig" rid="fig1-0267659112439597">1C</xref>). The device was positioned correctly, without any impairment of the aortic valve, semilunar subvalvular apparatus or pacemaker. There was no increase in aortic regurgitation. Repeat left ventriculogram showed no residual left to right shunt (<xref ref-type="fig" rid="fig1-0267659112439597">Figure 1D</xref>, supplementary file right panel). After the procedure, the patient’s symptoms regressed.</p>
<fig id="fig1-0267659112439597" position="float">
<graphic xlink:href="10.1177_0267659112439597-fig1.tif"/>
</fig>
</sec>
<sec id="section3-0267659112439597" sec-type="discussion">
<title>Discussion</title>
<p>This case showed that percutanous closure of a VSD in a patient with a mitral valve replacement operation and a permanent pacemaker can be performed safely. There are a few reports about percutaneous closure of post-op VSDs with acceptable results and limited complications<sup><xref ref-type="bibr" rid="bibr3-0267659112439597">3</xref>,<xref ref-type="bibr" rid="bibr5-0267659112439597">5</xref>,<xref ref-type="bibr" rid="bibr6-0267659112439597">6</xref></sup>. In this case, the existence of a permanent pacemaker makes the closure technique more complicated because of the risk of displacement of or damaging of the leads. As conduction tissue can run near the edges of the VSD and can be damaged by manipulation of the device, (the risk is more important if the VSD is located near the aortic or tricuspid valve) temporary or permanent atrioventricular block can occur<sup><xref ref-type="bibr" rid="bibr3-0267659112439597">3</xref>,<xref ref-type="bibr" rid="bibr7-0267659112439597">7</xref></sup>. Since the patient had already got a permanent pacemaker, there was no risk considered for this patient.</p>
<p>Post-op or iatrogenic VSDs are rare complications; most of them are residual shunts after aortic or VSD surgeries<sup><xref ref-type="bibr" rid="bibr1-0267659112439597">1</xref></sup>. However, the mechanism of VSD following hypertrophic obstructive cardiomyopathy operation is different from VSDs after aortic or congenital VSD operations. In VSDs after aortic or congenital VSD operations, the septum is relatively thin and particularly firm and fibrotic; in hypertrophic obstructive cardiomyopathy, the septum is relatively thick, depending on the amount of myocardial tissue excised during surgery<sup><xref ref-type="bibr" rid="bibr2-0267659112439597">2</xref></sup>. The Amplatzer muscular VSD occluder (AGA Medical, Plymouth, MN, USA) is the only device specifically designed for congenital muscular VSDs. Similar to the Amplatzer septal occluder (ASO) for ASDs, the muscular VSD occluder is made of nitinol wire mesh in the form of a self-expandable double-disc device. The mechanism of closure involves stenting of the actual defect by the waist and subsequent thrombus formation within the device and eventual complete endothelialization<sup><xref ref-type="bibr" rid="bibr1-0267659112439597">1</xref></sup>. The waist of a standard Amplatzer Muscular VSD Occluder is 7 mm in length. In VSD surgery following septal myectomy, the incision is not always regular and the rims can be relatively thin. In this case, the Standard Amplatzer occluder device was used. However, Spies et al. had used the Amplatzer Muscular VSD PI Occluder, designed for closure of post-myocardial infarction VSDs, which has a waist length of 11 mm and stated that they may accommodate better the thicker septum in patients following septal myectomy<sup><xref ref-type="bibr" rid="bibr2-0267659112439597">2</xref></sup>. Al-Kashkari et al. showed that percutaneous closure with Amplatzer devices in different types of adult congenital and acquired (non-postinfarct) VSDs, in 28 cases in approximately 5-7 years follow-up, was safe and effective<sup><xref ref-type="bibr" rid="bibr8-0267659112439597">8</xref></sup>.</p>
<p>Moreover, there are reported cases about VSDs that were closed percutaneously after septal alcohol ablation. Since there are no sternotomies prior to VSD in these cases, surgery is also a preferable option<sup><xref ref-type="bibr" rid="bibr4-0267659112439597">4</xref>-6,<xref ref-type="bibr" rid="bibr9-0267659112439597">9</xref>,<xref ref-type="bibr" rid="bibr10-0267659112439597">10</xref></sup>.</p>
<p>In conclusion, physicians should be aware that percutaneous closure of VSD following septal myectomy in patients with hypertrophic obstructive cardiomyopathy may be an alternative method for treatment of this unexpected complication.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>This research received no specific grant from any funding agency in the public, commercial, or not for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0267659112439597">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Spies</surname><given-names>C</given-names></name>
<name><surname>Cao</surname><given-names>Q-L</given-names></name>
<name><surname>Hijazi</surname><given-names>ZM</given-names></name>
</person-group>. <article-title>Transcatheter closure of congenital and acquired septal defects</article-title>. <source>Europian Heart Journal supplements</source> (<year>2010</year>) <volume>12</volume>(<supplement>supplement E</supplement>), <fpage>E24</fpage>–<lpage>E34</lpage>.</citation>
</ref>
<ref id="bibr2-0267659112439597">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Spies</surname><given-names>C</given-names></name>
<name><surname>Ujivari</surname><given-names>F</given-names></name>
<name><surname>Schraeder</surname><given-names>R.</given-names></name>
</person-group> <article-title>Transcatheter closure of a ventricular septal defect following myectomy for hypertrophic obstructive cardiomyopathy</article-title>. <source>Cardiology</source> <year>2009</year>; <volume>112</volume>(<issue>1</issue>): <fpage>31</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr3-0267659112439597">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Wolf</surname><given-names>D</given-names></name>
<name><surname>Taeymans</surname><given-names>Y</given-names></name>
<name><surname>Suys</surname><given-names>B</given-names></name>
<name><surname>Matthys</surname><given-names>D</given-names></name>
<name><surname>Van Nooten</surname><given-names>G</given-names></name>
</person-group>. <article-title>Percutaneous closure of a ventricular septal defect after surgical treatment of hypertrophic cardiomyopathy</article-title>. <source>J Thorac Cardiovasc Surg</source> <year>2006</year> <month>Jul</month>; <volume>132</volume>(<issue>1</issue>): <fpage>173</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr4-0267659112439597">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rigopoulos</surname><given-names>AG</given-names></name>
<name><surname>Seggewiss</surname><given-names>H.</given-names></name>
</person-group> <article-title>A decade of percutaneous septal ablation in hypertrophic cardiomyopathy</article-title>. <source>Circ J</source> <year>2010</year> <month>Dec</month> <day>24</day>; <volume>75</volume>(<issue>1</issue>): <fpage>28</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr5-0267659112439597">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chessa</surname><given-names>M</given-names></name>
<name><surname>Carminati</surname><given-names>M</given-names></name>
<name><surname>Cao</surname><given-names>QL</given-names></name>
<etal/>
</person-group>. <article-title>Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device</article-title>. <source>J Invasive Cardiol</source> <year>2002</year> <month>Jun</month>; <volume>14</volume>(<issue>6</issue>): <fpage>322</fpage>–<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr6-0267659112439597">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knauth</surname><given-names>AL</given-names></name>
<name><surname>Lock</surname><given-names>JE</given-names></name>
<name><surname>Perry</surname><given-names>SB</given-names></name>
<name><surname>McElhinney</surname><given-names>DB</given-names></name>
<name><surname>Gauvreau</surname><given-names>K</given-names></name>
<name><surname>Landzberg</surname><given-names>MJ.</given-names></name>
</person-group> <article-title>Transcatheter device closure of congenital and postoperative residual ventricular septal defects</article-title>. <source>Circulation</source> <year>2004</year> <month>Aug</month> <day>3</day>; <volume>110</volume>(<issue>5</issue>): <fpage>501</fpage>–<lpage>507</lpage>.</citation>
</ref>
<ref id="bibr7-0267659112439597">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Seggewiss</surname><given-names>H.</given-names></name>
</person-group> <article-title>Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy</article-title>. <source>Curr Cardiol Rep</source> <year>2001</year> <month>Mar</month>; <volume>3</volume>(<issue>2</issue>): <fpage>160</fpage>–<lpage>166</lpage>.</citation>
</ref>
<ref id="bibr8-0267659112439597">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Al-Kashkari</surname><given-names>W</given-names></name>
<name><surname>Balan</surname><given-names>P</given-names></name>
<name><surname>Kavinsky</surname><given-names>CJ</given-names></name>
<name><surname>Cao</surname><given-names>QL</given-names></name>
<name><surname>Hijazi</surname><given-names>ZM.</given-names></name>
</person-group> <article-title>Percutaneous device closure of congenital and iatrogenic ventricular septal defects in adult patients</article-title>. <source>Catheter Cardiovasc Interv</source> <year>2011</year> <month>Feb</month> <day>1</day>; <volume>77</volume>(<issue>2</issue>): <fpage>260</fpage>–<lpage>267</lpage>.</citation>
</ref>
<ref id="bibr9-0267659112439597">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aroney</surname><given-names>CN</given-names></name>
<name><surname>Goh</surname><given-names>TH</given-names></name>
<name><surname>Hourigan</surname><given-names>LA</given-names></name>
<name><surname>Dyer</surname><given-names>W.</given-names></name>
</person-group> <article-title>Ventricular septal rupture following nonsurgical septal reduction for hypertrophic cardiomyopathy: treatment with percutaneous closure</article-title>. <source>Catheter Cardiovasc Interv</source> <year>2004</year> <month>Mar</month>; <volume>61</volume>(<issue>3</issue>): <fpage>411</fpage>–<lpage>414</lpage>.</citation>
</ref>
<ref id="bibr10-0267659112439597">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Agarwal</surname><given-names>S</given-names></name>
<name><surname>Tuzcu</surname><given-names>EM</given-names></name>
<name><surname>Desai</surname><given-names>MY</given-names></name>
<etal/>
</person-group>. <article-title>Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy</article-title>. <source>J Am Coll Cardiol</source> <year>2010</year> <month>Feb</month> <day>23</day>; <volume>55</volume>(<issue>8</issue>): <fpage>823</fpage>–<lpage>834</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>